Mirum Pharmaceuticals has partnered with PreventionGenetics to offer a no-cost genetic testing program to qualifying patients to help identify peroxisome biogenesis disorder-Zellweger spectrum disorder (PBD-ZSD) and other disorders within the states offering X-linked adrenoleukodystrophy (X-ALD) newborn screening programs.
Testing will be offered to children who screened positive for X-ALD on initial state newborn screen but negative for disease after further laboratory testing.
